Auvi-Q
Payments companies reported to CMS as associated with Auvi-Q. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Auvi-Q, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Auvi-Q
These are the largest totals companies reported as associated with Auvi-Q. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ruchi Gupta | Chicago, IL | Pediatrics | $32,010.09 |
| Vivian Hernandez-Trujillo | Miami Lakes, FL | Pediatric Allergy/Immunology | $25,405.49 |
| Joyce Rabbat | Maywood, IL | Allergy & Immunology | $19,230.74 |
| Susan Laubach | San Diego, CA | Allergy & Immunology | $18,618.92 |
| Roxanne Oriel | Great Neck, NY | Allergy & Immunology | $17,689.42 |
| Jennifer Kim | Glenview, IL | Pediatric Allergy/Immunology | $14,442.34 |
| James Sublett | Louisville, KY | Allergy & Immunology | $14,180.29 |
| Edward Read | Richmond, VA | Emergency Medicine | $14,047.40 |
| Tina Zecca | Little Silver, NJ | Allergy & Immunology | $13,604.83 |
| Todd Mahr | La Crosse, WI | Pediatric Allergy/Immunology | $13,340.47 |
Prescribed Auvi-Q?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.